Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma)
about
Update on biomarkers in systemic sclerosis: tools for diagnosis and treatmentProteome-wide analysis and CXCL4 as a biomarker in systemic sclerosisGlobal chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin.Application of biomarkers to clinical trials in systemic sclerosis.von Willebrand factor propeptide: biology and clinical utilityVon Willebrand factor, red cell fragmentation, and disease activity in systemic lupus erythematosus.Bosentan regulates the expression of adhesion molecules on circulating T cells and serum soluble adhesion molecules in systemic sclerosis-associated pulmonary arterial hypertensionTissue factor: A potent stimulator of Von Willebrand factor synthesis by human umbilical vein endothelial cells.Dendritic cells maintain dermal adipose-derived stromal cells in skin fibrosis.Mechanisms of vascular damage in systemic sclerosis.The pathogenesis of systemic sclerosis revisited.Biomarkers in systemic sclerosis.Update on etiopathogenesis of systemic sclerosis.Biomarkers in systemic sclerosis: Their potential to predict clinical courses.Baseline vWF factor predicts the development of elevated pulmonary artery pressure in systemic sclerosis.Angiogenin and SDF-1α serum concentration in patients with systemic sclerosis in relation to clinical status.Effects of iloprost on adhesion molecules and F1 + 2 in peripheral ischemia.Microvascular involvement in Systemic Sclerosis and Systemic Lupus Erythematosus.ADAMTS13 deficiency and immunological abnormalities in patients with systemic sclerosis.The Use of Phage Display and Yeast Based Expression System for the Development of a Von Willebrand Factor Propeptide Assay: Development of a Von Willebrand Factor Propeptide Assay.Single Cell RNA Sequencing Identifies HSPG2 and APLNR as Markers of Endothelial Cell Injury in Systemic Sclerosis Skin
P2860
Q26995542-014FF4C2-FAE9-48F9-B190-F36AFA8D42B3Q33693955-67A5BE3B-78F2-45D4-9F64-37110D6A410FQ33826259-19784BD5-F2EC-4D29-BE29-24B2F86D6D11Q35681874-6A38E1B5-2772-4B5C-BDF0-71AE9983F438Q36143225-5B8BC7EB-A991-4B1C-8ACD-09A31A582BAAQ36908457-097281AE-6264-4E25-9A7C-45CF832E1D63Q36930652-2EAD1CB1-80AF-4D83-A506-D6A00CF53D62Q37348644-35F6543A-F664-4F95-96E6-EF10FE982746Q37395851-A8E7B267-A456-4962-84BB-0E6E56B1B35AQ37622943-42698436-B22E-48A1-87DC-C95657035D67Q37678280-51F9ED94-65D9-4AD7-A1B4-F2C76B84A4A4Q37730018-1C64AABF-0844-4E4B-97A4-A71A36361683Q38183300-D24F968D-F8A8-4D1C-8E35-172208806C88Q38701985-E2B4CE56-66B4-42DA-917C-EA3008BD3DB1Q39616227-8A7B1333-6B19-40F8-9DE3-79448543154CQ40413712-87682DEA-F226-4529-AD94-F4B5454BA01FQ44282448-3F477D6C-C623-4112-B599-0BA6225C193AQ47660081-F60BFF6E-A94A-40EA-A1DD-B15E4C52B926Q55380582-D5D7F196-5A16-4304-8DA1-6CB57229E9AFQ55472468-8D232E78-1BF5-4224-B526-8090186FBAACQ57486499-6081386F-5738-42C4-9B45-7BC3424FC0D5
P2860
Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma)
description
2001 nî lūn-bûn
@nan
2001 թուականին հրատարակուած գիտական յօդուած
@hyw
2001 թվականին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Von Willebrand factor propepti ...... stemic sclerosis (scleroderma)
@ast
Von Willebrand factor propepti ...... stemic sclerosis (scleroderma)
@en
Von Willebrand factor propepti ...... stemic sclerosis (scleroderma)
@nl
type
label
Von Willebrand factor propepti ...... stemic sclerosis (scleroderma)
@ast
Von Willebrand factor propepti ...... stemic sclerosis (scleroderma)
@en
Von Willebrand factor propepti ...... stemic sclerosis (scleroderma)
@nl
prefLabel
Von Willebrand factor propepti ...... stemic sclerosis (scleroderma)
@ast
Von Willebrand factor propepti ...... stemic sclerosis (scleroderma)
@en
Von Willebrand factor propepti ...... stemic sclerosis (scleroderma)
@nl
P2093
P2860
P3181
P356
P1476
Von Willebrand factor propepti ...... stemic sclerosis (scleroderma)
@en
P2093
C B Wollheim
F A Wollheim
U M Vischer
P2860
P2888
P304
P3181
P356
10.1186/AR295
P407
P577
2001-01-01T00:00:00Z